SURG Valuation

Surgepays Inc

Add to Watchlist

Advanced Chart

2.700

+0.06(2.273%)1D

Overview
Forecast
Valuation
Earnings

SURG Relative Valuation

SURG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SURG is overvalued; if below, it's undervalued.

Historical Valuation

Surgepays Inc (SURG) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.38 is considered Undervalued compared with the five-year average of -8.85. The fair price of Surgepays Inc (SURG) is between 4.87 to 9.11 according to relative valuation methord. Compared to the current price of 2.64 USD , Surgepays Inc is Undervalued By 45.75%.

Relative Value

Fair Zone

4.87-9.11

Current Price：2.64

45.75%

Undervalued

-18.62

Trailing

Forward

-105.95

EV/EBITDA

Surgepays Inc. (SURG) has a current EV/EBITDA of -105.95. The 5-year average EV/EBITDA is -2.46. The thresholds are as follows: Strongly Undervalued below -44.13, Undervalued between -44.13 and -23.30, Fairly Valued between 18.37 and -23.30, Overvalued between 18.37 and 39.20, and Strongly Overvalued above 39.20. The current Forward EV/EBITDA of -105.95 falls within the Strongly Undervalued range.

-28.01

EV/EBIT

Surgepays Inc. (SURG) has a current EV/EBIT of -28.01. The 5-year average EV/EBIT is -2.28. The thresholds are as follows: Strongly Undervalued below -38.39, Undervalued between -38.39 and -20.33, Fairly Valued between 15.77 and -20.33, Overvalued between 15.77 and 33.83, and Strongly Overvalued above 33.83. The current Forward EV/EBIT of -28.01 falls within the Undervalued range.

0.39

Surgepays Inc. (SURG) has a current PS of 0.39. The 5-year average PS is 0.50. The thresholds are as follows: Strongly Undervalued below -0.26, Undervalued between -0.26 and 0.12, Fairly Valued between 0.89 and 0.12, Overvalued between 0.89 and 1.27, and Strongly Overvalued above 1.27. The current Forward PS of 0.39 falls within the Historic Trend Line -Fairly Valued range.

-24.81

P/OCF

Surgepays Inc. (SURG) has a current P/OCF of -24.81. The 5-year average P/OCF is 5.10. The thresholds are as follows: Strongly Undervalued below -49.19, Undervalued between -49.19 and -22.04, Fairly Valued between 32.25 and -22.04, Overvalued between 32.25 and 59.39, and Strongly Overvalued above 59.39. The current Forward P/OCF of -24.81 falls within the Undervalued range.

0.00

P/FCF

Surgepays Inc. (SURG) has a current P/FCF of 0.00. The 5-year average P/FCF is -0.36. The thresholds are as follows: Strongly Undervalued below -12.09, Undervalued between -12.09 and -6.23, Fairly Valued between 5.51 and -6.23, Overvalued between 5.51 and 11.38, and Strongly Overvalued above 11.38. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Surgepays Inc (SURG) has a current Price-to-Book (P/B) ratio of 448.75. Compared to its 3-year average P/B ratio of 38.45 , the current P/B ratio is approximately 1067.17% higher. Relative to its 5-year average P/B ratio of 25.14, the current P/B ratio is about 1685.18% higher. Surgepays Inc (SURG) has a Forward Free Cash Flow (FCF) yield of approximately -68.69%. Compared to its 3-year average FCF yield of -7.76%, the current FCF yield is approximately 785.51% lower. Relative to its 5-year average FCF yield of -17.67% , the current FCF yield is about 288.80% lower.

458.95

P/B

Median3y

38.45

Median5y

25.14

-66.87

FCF Yield

Median3y

-7.76

Median5y

-17.67

Competitors Valuation Multiple

The average P/S ratio for SURG's competitors is 2.56, providing a benchmark for relative valuation. Surgepays Inc Corp (SURG) exhibits a P/S ratio of 0.39, which is -84.71% above the industry average. Given its robust revenue growth of -23.65%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Ruanyun Edai Technology Inc

YXT.Com Group Holding Ltd

Performance Decomposition

Market capitalization of SURG increased by 64.63% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.51 to -1.10.

The secondary factor is the Revenue Growth, contributed -23.65%to the performance.

Overall, the performance of SURG in the past 1 year is driven by P/E Change. Which is more unsustainable.

-23.65%

15.09M → 11.52M

Revenue Growth

-28.01%

-85.41 → -61.49

Margin Expansion

116.29%

-0.51 → -1.10

P/E Change

64.63%